Meta-analysis: Diagnostic medical radiation exposure in inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 5, 2012, Pages 529-539

  Chatu, S ^a   Subramanian, V ^b   Pollok, R C G ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ABDOMINAL SURGERY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; ENTERITIS; HUMAN; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RISK FACTOR; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

HUMANS; INFLAMMATORY BOWEL DISEASES; RADIATION INJURIES; RADIONUCLIDE IMAGING; RADIOTHERAPY DOSAGE; RISK FACTORS;

EID: 84856708049     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04975.x     Document Type: Article

References (46)

1. Williams H, Walker D, Orchard TR,. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008; 10: 597-605.
2. Loftus EV Jr,. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17. (Pubitemid 38649869)
3. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI,. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005; 100: 2724-9.
4. Loftus EV Jr,. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006; 35: 517-31. (Pubitemid 44307577)
5. Persson PG, Karlen P, Bernell O, et al,. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994; 107: 1675-9. (Pubitemid 24357620)
6. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V,. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-85. (Pubitemid 43736578)
7. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD,. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54: 1121-5. (Pubitemid 41025906)
8. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-84. (Pubitemid 350190758)
9. Koenig TR, Wolff D, Mettler FA, Wagner LK,. Skin injuries from fluoroscopically guided procedures: part 1, characteristics of radiation injury. AJR Am J Roentgenol 2001; 177: 3-11. (Pubitemid 32578043)
10. O'Neill SB, O'Connor OJ, McWilliams SR, Shanahan F, Maher MM,. Minimization of radiation exposure due to computed tomography in inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2011; 35: 105-10.
11. Brenner DJ, Doll R, Goodhead DT, et al,. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A 2003; 100: 13761-6. (Pubitemid 37499140)
12. Hall EJ, Brenner DJ,. Cancer risks from diagnostic radiology. Br J Radiol 2008; 81: 362-78. (Pubitemid 351743850)
13. Kroeker KI, Lam S, Birchall I, Fedorak RN,. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol 2011; 45: 34-9.
14. Cardis E, Vrijheid M, Blettner M, et al,. The 15-Country Collaborative Study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 2007; 167: 396-416. (Pubitemid 351292972)
15. Vrijheid M, Cardis E, Blettner M, et al,. The 15-Country Collaborative Study of cancer risk among radiation workers in the nuclear industry: design, epidemiological methods and descriptive results. Radiat Res 2007; 167: 361-79. (Pubitemid 351292970)
16. De Gonzalez AB, Darby S,. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004; 363: 345-51. (Pubitemid 38169539)
17. Brenner D, Elliston C, Hall E, Berdon W,. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176: 289-96. (Pubitemid 32105628)
18. BEIR VII-Phase 2. Health risks from exposure to low levels of ionizing radiation. National Academies Press, 2005. Available at: http://www.nap.edu/ catalog/11340.html.
19. Desmond AN, O'Regan K, Curran C, et al,. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008; 57: 1524-9.
20. Peloquin JM, Pardi DS, Sandborn WJ, et al,. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008; 103: 2015-22.
21. Van AG, Dignass A, Panes J, et al,. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27.
22. Mowat C, Cole A, Windsor A, et al,. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571-607.
23. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
24. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
25. Cochrane WG,. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60. (Pubitemid 37088507)
27. Egger M, Davey SG, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
28. Wells GA, Shea B, O'Connell D, et al,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analysis. The Ottawa Health Research Institution 2011.
29. Fuchs Y, Markowitz J, Weinstein T, Kohn N, Choi-Rosen J, Levine J,. Pediatric inflammatory bowel disease and imaging-related radiation: are we increasing the likelihood of malignancy? J Pediatr Gastroenterol Nutr 2011; 52: 280-5.
30. Levi Z, Fraser E, Krongrad R, et al,. Factors associated with radiation exposure in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009; 30: 1128-36.
31. Newnham E, Hawkes E, Surender A, James SL, Gearry R, Gibson PR,. Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy? Aliment Pharmacol Ther 2007; 26: 1019-24. (Pubitemid 47416293)
32. Palmer L, Herfarth H, Porter CQ, Fordham LA, Sandler RS, Kappelman MD,. Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases. Am J Gastroenterol 2009; 104: 2816-23.
33. Sauer CG, Kugathasan S, Martin DR, Applegate KE,. Medical radiation exposure in children with inflammatory bowel disease estimates high cumulative doses. Inflamm Bowel Dis 2011; 17: 2326-32.
34. Hafeez R, Greenhalgh R, Rajan J, et al,. Use of small bowel imaging for the diagnosis and staging of Crohn's disease-a survey of current UK practice. Br J Radiol 2011; 84: 508-17.
35. Jacob K, Vivian G, Steel JR,. X-ray dose training: are we exposed to enough? Clin Radiol 2004; 59: 928-34. (Pubitemid 39276934)
36. Renston JP, Connors AF Jr, DiMarco AF,. Survey of physicians' attitudes about risks and benefits of chest computed tomography. South Med J 1996; 89: 1067-73. (Pubitemid 26376492)
37. Shiralkar S, Rennie A, Snow M, Galland RB, Lewis MH, Gower-Thomas K,. Doctors' knowledge of radiation exposure: questionnaire study. BMJ 2003; 327: 371-2. (Pubitemid 37000070)
38. Fletcher JG, Fidler JL, Bruining DH, Huprich JE,. New concepts in intestinal imaging for inflammatory bowel diseases. Gastroenterology 2011; 140: 1795-806.
39. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al,. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis 2010; 17: 1073-80.
40. Horsthuis K, Bipat S, Bennink RJ, Stoker J,. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008; 247: 64-79.
41. Sinha R, Nwokolo C, Murphy PD,. Magnetic resonance imaging in Crohn's disease. BMJ 2008; 336: 273-6. (Pubitemid 351251630)
42. Fidler J,. MR imaging of the small bowel. Radiol Clin North Am 2007; 45: 317-31. (Pubitemid 46719275)
43. Pallotta N, Tomei E, Viscido A, et al,. Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis 2005; 11: 146-53. (Pubitemid 40711219)
44. Pallotta N, Vincoli G, Montesani C, et al,. Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn's disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis 2011; 18: 74-84.
45. Parente F, Maconi G, Bollani S, et al,. Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 2002; 50: 490-5. (Pubitemid 34638867)
46. Parente F, Greco S, Molteni M, et al,. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn's disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut 2004; 53: 1652-7. (Pubitemid 39434111)